Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-124573
Filing Date
2025-05-22
Accepted
2025-05-22 08:09:03
Documents
4
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 6-K d926951d6k.htm 6-K 8884
2 EX-99.1 d926951dex991.htm EX-99.1 20327
3 GRAPHIC g926951dsp2.jpg GRAPHIC 8447
4 GRAPHIC g926951g0521002831863.jpg GRAPHIC 2601
  Complete submission text file 0001193125-25-124573.txt   40519
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25974774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)